When you hear that a woman lost her uterus, and her newborn is in a coma because two obstetrician gynaecologists went into a fistfight in the delivery room of a […]
Latest articles
Tony Waterston: ICAN, you can, we can: banning the bomb in Basel
Being a member of a Nobel peace prize-winning organisation confers pride but not necessarily a sense of direction. Both were overwhelmingly present at the 19th Congress of International Physicians for […]
Kashif Shafique and colleagues on the public health challenges of the flood in Pakistan
As average global temperatures rise, the stability of the monsoon rainfall, over the past century, has been uncertain. It has long been expected in South Asian regions that heavy rain […]
Richard Lehman’s journal review – 6 September 2010
JAMA 1 Sep 2010 Vol 304 967 A couple of weeks ago, the BMJ published a rather strange piece about the terrible psychological effects of chemical castration in men with […]
Research highlights – 3 September 2010
“Research highlights” is a weekly round-up of research papers appearing in the print BMJ. We start off with this week’s research questions, before providing more detail on some individual research […]
Anjum Khan on HIV and TB in Uganda
Uganda is the colour blue, that intense, clear sky. Uganda is green; bright, vivid trees swimming with life. Uganda is red, crumbling soil everywhere. Some things stay with me; the […]
US highlights – 3 September 2010
After months of preparation, bmj.com has just moved to a new technical platform. The website looks different and has many new and improved features. However, a few features and functions […]
Julian Sheather: Doctors’ religious beliefs and end of life care
Early on in my ‘career’ in ethics – I put the word in scare quotes not only because the idea that my rather shapeless crashing about should be dignified with […]
Richard Smith: Medicine needs to feel defeat
Defeat is a marvellous thing. It can refresh in a way that never happens after victory. Wouldn’t it be wonderful, I thought this morning as I awoke, if medicine were […]
James Raftery on bevacizumab for metastatic colorectal cancer
Roche’s bevacizumab (Avastin) is in the news again. This has a reasonable claim to be a wonder drug, but for macular degeneration, a disease for which Roche refuses to license […]